Deadline for USCAP Journal Subscriptions for 2023 has been extended to December 1st

Categoria: Notícias Publicado por: editorst Publicado em: 16/11/2022

We are delighted to announce that USCAP has extended the deadline for subscriptions to December 1st. There is no need to reply if you have already received or acted on this.


As has been done in the past, Divisions are responsible for collecting validated lists of your subscribers and receiving payment from them. With apologies that this may not have been clearly explained in our previous messages, but please DO NOT send the webform link below to individual members. Divisions must send us the list of subscribers since only Divisions retain lists of their IAP members, which, in turn, qualifies them for the discount. An Excel spreadsheet is provided for this purpose on the online form.


To take advantage send in your list of subscribers, please use the form below:


Journal Subscriptions


Please note:

  • Modern Pathology and Laboratory Investigation will move to an online-only format as of January 2023.  Journals will no longer be printed.
  • Both online journals will be available to IAP members with a special price of $75 USD per year for both journals.  There will no longer be an option to choose just one journal.

Please submit your subscriptions to us as soon as possible so that we can process them on your behalf of your Division members.  If you have any questions about the journal subscription offering above, please contact USCAP’s membership services coordinator, Teresa Powers, at


Veja também


Programa de Especialização Médica em Patologia Oncológica do Hospital Sírio-Libanês de SP

21 de novembro de 2023 - Notícias

Programa de Aperfeiçoamento (Fellowship) em Patologia Oncológica em Natal/RN

10 de novembro de 2023 - Notícias

Programa de Aperfeiçoamento Médico em Anatomia Patológica – Fellowship Diagnóstika

10 de novembro de 2023 - Notícias

Concurso de residência médica em Patologia/2024 para a Rede D’Or em São Paulo

10 de novembro de 2023 - Notícias
Ver todas as matérias
Voltar ao topo